Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Jost FischerDirector | Aeon BiopharmaAEON | Open-market buy | 25/05/21 | 25/05/23 | 60,000 sh | $0.49 | $29,400 | +29.0% |
Aeon BiopharmaAEON | Open-market buy | 25/05/19–25/05/20 | 25/05/21 | 110,000 sh2 trades | $0.51avg. | $55,600 | +113.7% | |
Strathspey Crown Holdings Group10% Owner | Aeon BiopharmaAEON | Open-market sale | 23/08/11 | 23/08/14 | 7,380,394 sh | $10.00 | $73,803,940 | −78.4% |